Does immunostaining effectively upstage colorectal cancer by identifying micrometastatic nodal disease?

Author： Madbouly Khaled Senagore Anthony Mukerjee Abir Delaney Conor Connor Jason Fazio Victor

ISSN： 0179-1958

Source： International Journal of Colorectal Disease, Vol.22, Iss.1, 2007-01, pp. : 39-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Duration of symptoms and spread of colorectal cancer: a short history does not mean early disease

By Kiran P R Glass R E

Annals of The Royal College of Surgeons of England, Vol. 84, Iss. 6, 2002-11 ,pp. : 381-385

The Royal College of Surgeons of England

Access to resources Recommend Favorite

Does “Conversion Chemotherapy” Really Improve Survival in Metastatic Colorectal Cancer Patients with Liver-Limited Disease?

By Kataoka K. Kanazawa A. Iwamoto S. Kato T. Nakajima A. Arimoto A.

World Journal of Surgery, Vol. 38, Iss. 4, 2014-04 ,pp. : 936-946

Springer Publishing Company

Access to resources Recommend Favorite

Does coeliac disease affect colorectal practice?

By Sanders David Hurlstone David Brown Steve

International Journal of Colorectal Disease, Vol. 22, Iss. 6, 2007-06 ,pp. : 565-570

Springer Publishing Company

Access to resources Recommend Favorite

Laparoscopic resections for colorectal cancer: Does conversion survival?

By Moloo H.

Surgical Endoscopy, Vol. 18, Iss. 5, 2004-05 ,pp. : 732-735

Springer Publishing Company

Access to resources Recommend Favorite

Oligometastatic Disease in Colorectal Cancer - How to Proceed?

Visceral Medicine (formerly: Viszeralmedizin), Vol. 33, Iss. 1, 2017-02 ,pp. : 23-28

Karger

Access to resources Recommend Favorite